UDG Healthcare (UDG) Given “Hold” Rating at Liberum Capital

Liberum Capital reaffirmed their hold rating on shares of UDG Healthcare (LON:UDG) in a research report sent to investors on Tuesday. They currently have a GBX 884 ($11.84) price target on the stock.

A number of other brokerages also recently commented on UDG. Jefferies Group reaffirmed a hold rating and set a GBX 785 ($10.51) target price on shares of UDG Healthcare in a research note on Thursday, August 3rd. Stifel Nicolaus reaffirmed a hold rating and set a GBX 775 ($10.38) target price on shares of UDG Healthcare in a research note on Thursday, August 3rd. N+1 Singer lifted their target price on shares of UDG Healthcare from GBX 770 ($10.31) to GBX 841 ($11.26) and gave the stock a hold rating in a research note on Wednesday, November 1st. Numis Securities reaffirmed a hold rating and set a GBX 730 ($9.78) target price on shares of UDG Healthcare in a research note on Thursday, August 3rd. Finally, Peel Hunt reaffirmed an add rating and set a GBX 830 ($11.12) target price on shares of UDG Healthcare in a research note on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company. The company presently has a consensus rating of Hold and an average price target of GBX 831.43 ($11.13).

UDG Healthcare (UDG) opened at GBX 857 ($11.48) on Tuesday. UDG Healthcare has a 52 week low of GBX 632.50 ($8.47) and a 52 week high of GBX 963 ($12.90).

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/02/udg-healthcare-udg-given-hold-rating-at-liberum-capital.html.

UDG Healthcare Company Profile

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for UDG Healthcare (LON:UDG)

Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply